Viruses interact with and regulate many host metabolic pathways in order to advance the viral life cycle and counteract intrinsic and extrinsic antiviral responses. The human adenovirus (Ad) early protein E4-ORF3 forms a unique scaffold throughout the nuclei of infected cells and inhibits multiple antiviral defenses, including a DNA damage response (DDR) and an interferon response. We previously reported that the Ad5 E4-ORF3 protein induces sumoylation of Mre11 and Nbs1, which are essential for the DDR, and their relocalization into E4-ORF3-induced nuclear inclusions is required for this modification to occur. In this study, we sought to analyze a global change in ubiquitin-like (Ubl) modifications, with particular focus on SUMO3, by the Ad5 E4-ORF3 protein and to identify new substrates with these modifications. By a comparative proteome-wide approach utilizing immunoprecipitation/mass spectrometry, we found that Ubl modifications of 166 statistically significant lysine sites in 51 proteins are affected by E4-ORF3, and the proteome of modifications spans a diverse range of cellular functions. Ubl modifications of 92% of these identified sites were increased by E4-ORF3. We further analyzed SUMO3 conjugation of several identified proteins. Our findings demonstrated a role for the Ad5 E4-ORF3 protein as a regulator of Ubl modifications and revealed new SUMO3 substrates induced by E4-ORF3. (1, 2) . Therefore, Ad has evolved several mechanisms to inhibit the cellular DDR early after infection. The incoming viral genome is coated with a basic viral core protein that may block recognition of the viral DNA by the cellular DDR machinery at the earliest stages of infection (3). Once Ad early protein synthesis ensues, two distinct mechanisms are employed to inhibit the DDR (1, 2). The Ad5 E1B-55K and E4-ORF6 proteins form an E3 ubiquitin (Ub) ligase complex with cellular proteins cullin 5 (CUL5), Rbx1, and elongins B and C (4, 5). Together, this complex leads to ubiquitin-mediated, proteasome-dependent degradation of cellular sensors of DNA damage, including Mre11, Rad50, and Nbs1 (the MRN complex) (6). Inhibition of cellular sensors of DNA damage blocks downstream signaling events and inhibits both DNA damage repair and cell cycle checkpoint signaling. The Ad5 E4-ORF3 protein sequesters MRN proteins into nuclear inclusions, termed nuclear tracks (7), within infected cell nuclei to inhibit MRN activity (6, 8). E4-ORF3 recruits numerous nuclear proteins into these structures, including promyelocytic leukemia (PML) and other PML-nuclear body (PML-NB)-associ- 
V
iruses interact with and regulate many host metabolic pathways to advance the viral life cycle and counteract intrinsic and extrinsic antiviral responses. Numerous examples with different DNA and RNA virus families demonstrate how viruses regulate host transcription, translation, DNA replication, and in certain cases, host cell posttranslational modifications. During adenovirus (Ad) infection, host cell DNA replication and translation are shut off in order to promote replication of the viral genome and translation of viral proteins. Additionally, Ad counteracts several intrinsic and interferon (IFN)-induced cellular, antiviral responses. For example, Ad infection triggers a cellular DNA damage response (DDR) that may impede the virus life cycle (1). The Ad virus particle contains a linear, double-stranded DNA genome of ϳ36 kbp in length. The open ends of this linear DNA are perceived by the infected cell as DNA damage, and a DDR may occur following Ad infection. If unabated, the cellular DDR actively inhibits viral DNA replication, in part by ligation of the viral DNA in an end-to-end manner which masks and mutates the origins of viral DNA replication. This process may block the entire viral replication cycle (1, 2) . Therefore, Ad has evolved several mechanisms to inhibit the cellular DDR early after infection. The incoming viral genome is coated with a basic viral core protein that may block recognition of the viral DNA by the cellular DDR machinery at the earliest stages of infection (3) . Once Ad early protein synthesis ensues, two distinct mechanisms are employed to inhibit the DDR (1, 2) . The Ad5 E1B-55K and E4-ORF6 proteins form an E3 ubiquitin (Ub) ligase complex with cellular proteins cullin 5 (CUL5), Rbx1, and elongins B and C (4, 5) . Together, this complex leads to ubiquitin-mediated, proteasome-dependent degradation of cellular sensors of DNA damage, including Mre11, Rad50, and Nbs1 (the MRN complex) (6) . Inhibition of cellular sensors of DNA damage blocks downstream signaling events and inhibits both DNA damage repair and cell cycle checkpoint signaling. The Ad5 E4-ORF3 protein sequesters MRN proteins into nuclear inclusions, termed nuclear tracks (7), within infected cell nuclei to inhibit MRN activity (6, 8) . E4-ORF3 recruits numerous nuclear proteins into these structures, including promyelocytic leukemia (PML) and other PML-nuclear body (PML-NB)-associ-ated proteins, such as Sp100 and Daxx, to inactivate cellular antiviral defense mechanisms induced by interferon (9, 10) .
We previously reported that Ad5 induces SUMO (small ubiquitin-like modifier) modification of Mre11 and Nbs1 during the early phase of infection (11) . We found that the E4-ORF3 protein is both necessary and sufficient to induce Mre11 and Nbs1 SUMO conjugation. Relocalization of Mre11 and Nbs1 into E4-ORF3-induced nuclear inclusions is required for this modification to occur. Upon wild-type Ad5 infection, Mre11 and Nbs1 sumoylation reaches a peak at early times after infection and declines thereafter. SUMO1 deconjugation from Nbs1 depends on degradation of Mre11 by the viral E1B-55K-E4-ORF6 E3 ubiquitin ligase complex, whereas SUMO2 deconjugation is independent of viral early gene products. Inhibition of viral DNA replication blocks SUMO2 deconjugation from Mre11 and Nbs1, indicating that a late-phase process is involved in their desumoylation. Our results provide direct evidence of Mre11 and Nbs1 sumoylation induced by the Ad5 E4-ORF3 protein and an important example that modification of a single substrate by both SUMO1 and SUMO2 is regulated through distinct mechanisms (11) . These findings suggest E4-ORF3-mediated relocalization of the MRN complex influences the cellular DNA damage response.
Posttranslational modification by SUMO is associated with the regulation of diverse cellular processes, including transcription, proliferation, apoptosis, the DDR, subcellular localization, protein stability, and intrinsic and innate immunity to pathogens (12, 13) . Vertebrates encode four SUMO isoforms: SUMO1 through SUMO4. SUMO1, SUMO2, and SUMO3 are ubiquitously expressed, whereas SUMO4 expression is found primarily in cells of the immune system (12, 13) . SUMO2 and SUMO3 have 95% amino acid homology in precursor form and 97% homology in mature form and are frequently referred to as SUMO2/3. SUMO1 and SUMO2/3 have only 50% homology and typically have unique substrate specificity. It is thought that in contrast to SUMO1, SUMO2/3 modification is regulated more dynamically in response to various stimuli, such as heat shock, oxidative stress, and pathogens, since the unconjugated, free SUMO2/3 population is larger than the free SUMO1 population in mammalian cells (12, 13) . SUMO proteins are synthesized as precursors that are cleaved after a C-terminal diglycine (GG) sequence by cellular SUMO proteases (SENPs). SUMO proteins are members of the ubiquitin-like (Ubl) family that also includes Nedd8, ISG15, and FAT10. These Ubls are small proteins, ϳ100 amino acids long, and are conjugated via a C-terminal glycine residue to the epsilon amine group of a lysine residue in the target substrate (K-ε-GG linkage). Covalent attachment of SUMO to a substrate occurs via a pathway analogous to the ubiquitin conjugation system. Processed SUMO is covalently linked to an E1-activating enzyme (SAE-1:SAE-2) via a thioester linkage between the E1 active site cysteine residue and the C-terminal SUMO glycine residue. SUMO is then transferred to an E2-conjugating enzyme (Ubc9 in humans). Ubc9 may directly transfer SUMO to a substrate or, alternatively, transfer SUMO to an E3 ligase followed by SUMO conjugation to a substrate. More than 10 SUMO E3 ligases have been described (12, 13) . It remains unclear how the sumoylation system confers substrate specificity and SUMO paralog specificity to a wide range of substrates using only one E2 SUMO enzyme and a limited number of E3 SUMO ligases. Some SUMO conjugation sites share the consensus sequence ⌿-K-X-D/E (⌿ is a large hydrophobic amino acid and X is any amino acid), but an increasing number of substrate conjugation sites have been identified that do not contain this consensus sequence. SUMO1 is conjugated as a monomer, whereas SUMO2/3 may be conjugated as monomers or multimers (12, 13) .
In this study, we sought to identify new substrates with ubiquitin-like modifications induced during the early phase of Ad infection by the E4-ORF3 protein. To date, only Mre11 and Nbs1 have been identified as E4-ORF3-induced SUMO substrates (11) . The E4-ORF3 protein predominantly induces SUMO2/3 conjugation of Mre11 and Nbs1 (11) . The detection of sumoylation is significantly complicated by the activity of SENPs in cellular extracts. Most of the previously described approaches to identify sumoylated substrates and map SUMO conjugation sites involve cell lysis under denaturing conditions followed by one of a number of SUMO enrichment approaches (14) (15) (16) (17) (18) (19) (20) . A method to map sumoylation sites by mass spectrometry (MS) was described that used a modified SUMO1 with an arginine residue engineered immediately N-terminal to the diglycine linkage site (21) . Trypsin cleavage of sumoylated substrates linked to this SUMO1 variant resulted in the release of a signature peptide containing a diglycine remnant attached to the amine group of the target lysine residue (K-ε-GG) (21) . An antibody was recently described that recognizes the same remnant motif of ubiquitin site conjugation following trypsin digestion, K-ε-GG (22) . We engineered a cell line that constitutively expresses His 6 -tagged SUMO3 in which the threonine at position 90 was changed to an arginine residue, SUMO3(T90R). SUMO3(T90R) was expressed at physiological levels, and the variant was found to be efficiently conjugated to both Mre11 and Nbs1 following wild-type Ad5 infection. We utilized this cell line in an immunoprecipitation/mass spectrometry analysis to identify new substrates whose Ubl modification is altered by Ad5 E4-ORF3. E4-ORF3-induced sumoylation was verified with candidate substrates, and new sumoylation substrates were identified by these analyses. 8 .0], 150 mM NaCl, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride [PMSF]), and boiled for 10 min. After centrifugation at 12,000 ϫ g for 10 min, 1.2 ml of immunoprecipitation (IP) dilution buffer (10 mM Tris [pH 8 .0], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 1 mM PMSF) was added to the supernatant. Lysates were precleared with protein G-agarose beads (Roche Applied Science) for 1 h and incubated overnight with either mouse IgG or mouse anti-Ub antibody (Stressgen), followed by incubation with protein G-agarose for 3 h. The beads were washed five times with IP dilution buffer and analyzed by 7.5% SDS-PAGE and Western blotting.
In vivo sumoylation assay. The parent HeLa cells or His 6 -tagged SUMO3-expressing HeLa cells were uninfected or infected with wild-type or E4-ORF3-deficient Ad5 for 7 h, and SUMO conjugates were prepared and analyzed as described previously (20) .
Immunofluorescence. For immunofluorescence analysis, the cells were grown on glass coverslips in a 24-well plate and fixed in methanol. After blocking in PBS containing 10% goat serum, cells were stained with the indicated antibodies. The Alexa 488-conjugated anti-mouse secondary antibody was from Molecular Probes, and the fluorescein isothiocyanate-conjugated anti-rabbit and tetramethyl rhodamine isothiocyanateconjugated anti-rat, anti-mouse, and anti-rabbit secondary antibodies were from Zymed. Nuclei were visualized by 4=,6-diamidino-2-phenylindole (DAPI) staining. Cell images were acquired on an Axiovert 200M digital deconvolution microscope (Zeiss) and analyzed using Axiovision software.
Cell preparation, protein extraction, and digestion. His 6 -SUMO3 (T90R)-expressing HeLa cells (2 ϫ 10 8 ) were infected with 200 particles per cell of wild-type Ad5 or E4-ORF3-deficient Ad5 for 1 h. At 7 h postinfection, cells were washed three times with PBS and collected by centrifugation at 2,000 ϫ g. Cell pellets were flash-frozen in liquid nitrogen and shipped on dry ice to Cell Signaling Technology Inc. (Danvers, MA) for UbiScan analysis by using the Ubiquitin Remnant Motif K-ε-GG rabbit monoclonal antibody (antibody 5562). Cells were lysed in urea lysis buffer (20 mM HEPES [pH 8.0], 9.0 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM glycerol-phosphate). Sonication of cell lysates was applied at 15 W output power twice for 20 s and once for 15 s. The resulting lysates were centrifuged at 20,000 ϫ g for 15 min to remove insoluble material. Protein extracts were reduced and carboxamidomethylated. After normalizing total protein for each sample, proteins were digested overnight using trypsin. Resulting peptides were separated from nonpeptide material by solid-phase extraction with Sep-Pak C 18 cartridges. Lyophilized peptides were resuspended in morpholinepropanesulfonic acid (MOPS) immunoaffinity purification buffer (50 mM MOPS [pH 7.2], 10 mM KH 2 PO 4 , and 50 mM NaCl) and clarified by centrifugation. Supernatants were mixed with slurries of immobilized PTMScan ubiquitin branch K-ε-GG motif antibody for 2.5 h at 4°C. Beads were pelleted by centrifugation and washed once in MOPS immunoaffinity purification buffer and four times with water. Peptides were eluted from beads with two sequential incubations in 0.15% trifluoroacetic acid (TFA), 10 min each, at room temperature. Eluted peptides were desalted over tips filled with C 18 packing material, eluted with 60% acetonitrile in 0.1% TFA, and lyophilized.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. The samples were run in duplicate to generate analytical replicates and increase the number of MS/MS identifications from each sample. Immunoprecipitated peptides were resuspended in 0.125% formic acid and loaded directly onto a 10-cm by 75-m PicoFrit capillary column packed with Magic C 18 AQ reverse-phase resin. The column was developed with a 90-min linear gradient of acetonitrile in 0.125% formic acid delivered at 280 nl/minute. Tandem mass spectra were collected with an linear trap quadropole (LTQ)-Orbitrap Velos hybrid mass spectrometer running XCalibur software (version 2.0.7; SP1) using a top 20 MS/MS method, a dynamic exclusion repeat count of one, and a repeat duration of 30 s. Real-time calibration of mass error was performed using lock mass with a singly charged polysiloxane ion with m/z 371.101237 (25) . MS spectra were collected in the Orbitrap component of the mass spectrometer, and MS/MS spectra were collected with the LTQ component.
Data analysis. Data processing was performed as described previously (25) . MS/MS spectra were evaluated using SEQUEST 3G and the SOR-CERER 2 platform from Sage-N Research (version 4.0; Milpitas, CA) (26) . Searches were performed against the most recent update of the NCBI Homo sapiens FASTA database (updated on 6 September 2010; release 43) containing 39,112 sequences, and the human adenovirus type 5 genome (AC_000008; updated on 8 December 2008), containing 36 sequences. A mass accuracy of Ϯ50 ppm was used for precursor ions and Ϯ1.0 Da for product ions. Enzyme specificity was limited to trypsin, with at least one tryptic (lysine or arginine)-containing terminus required per peptide and up to four missed cleavages allowed. Cysteine carboxamidomethylation was specified as a static modification, and oxidation of methionine was allowed as a variable modification. Results were filtered with a mass accuracy of Ϯ5 ppm on precursor ions and presence of the intended K-ε-GG motif. Reverse decoy databases were included for all searches to estimate false-positive rates, and peptide assignments were obtained using a 5% false-positive discovery rate in the Peptide Prophecy module of SOR-CERER 2 (27) . The results were further narrowed by applying a mass accuracy filter of Ϯ5 ppm of calculated m/z values, depending on the distribution and symmetry of the XCorr-versus-ppm plot for a given search result.
RESULTS

Validation of the SUMO3(T90R) cell line.
We sought to identify sites of SUMO conjugation altered by the E4-ORF3 protein during Ad5 infection by using a recently described antibody that recognizes the remnant motif of ubiquitin conjugation following trypsin digestion: K-ε-GG (PTMScan ubiquitin remnant motif antibody; Cell Signaling Technology [28] ). A lysine or arginine residue was not present at the N terminus of the GG residues in any of the SUMO isoforms (Fig. 1A) . Therefore, we engineered a cell line that constitutively expresses a His 6 -tagged SUMO3 in which the threonine at position 90 was changed to an arginine residue (21) , termed SUMO3(T90R); the GG residues in SUMO3 are present at positions 91 and 92 (Fig. 1A) . SUMO3(T90R) was tagged at the N terminus with His 6 to allow for protein purification under denaturing conditions using Ni-nitrilotriacetic acid (NTA)-agarose beads (20) . A HeLa cell clone expressing His 6 -SUMO3(T90R) at physiological levels relative to total SUMO2/3 levels in HeLa cells (Fig. 1B ) was selected and used for subsequent experiments. The His 6 -SUMO3(T90R) expression level was similar to that found in a previously described HeLa cell line expressing His 6 -SUMO3 (20) (Fig. 1B) . His 6 -SUMO3-or His 6 -SUMO3(T90R)-expressing HeLa cells were left uninfected or infected with wild-type Ad5 or E4-ORF3-deficient Ad5 (⌬E4-ORF3) for 7 h, and SUMO3 subcellular localization was evaluated by immunofluorescence. His 6 -SUMO3 and His 6 -SUMO3(T90R) were diffusely localized in the nuclei of uninfected cells with some puncta evident (Fig. 1D ). His 6 -SUMO3 and His 6 -SUMO3(T90R) were both relocalized into nuclear tracks containing the E4-ORF3 protein following infection with wild-type Ad5 (Fig. 1D ). Neither His 6 -SUMO3 nor His 6 -SUMO3(T90R) protein was relocalized following infection with E4-ORF3-deficient Ad5 (Fig. 1D) . We compared total SUMO3 conjugation patterns and Nbs1-specific SUMO3 conjugation patterns by using an in vivo sumoylation assay with His 6 -SUMO3 and His 6 -SUMO3(T90R) cells infected with wild-type Ad5 for 7 h. Total SUMO3 conjugation patterns were the same with His 6 -SUMO3 and His 6 -SUMO3(T90R) cells (Fig. 1C, lysate, bottom panel) , as was the pattern of Ad5 E4-ORF3-induced sumoylation of Nbs1 (Fig. 1C , His pulldown, top panel). RanGAP1, a major cellular SUMO substrate, served as a positive control for His 6 -SUMO3 capture in this experiment. These results substantiate that His 6 -SUMO3(T90R) is expressed at physiological levels in our HeLa cell line, and the T90R mutation of SUMO3 affects neither its conjugation properties nor subcellular localization in the absence or presence of Ad5 infection.
Proteomic identification of cellular proteins whose Ubl conjugation is regulated by Ad5 E4-ORF3. We aimed to identify new cellular substrates whose sumoylation is regulated by the Ad5 E4-ORF3 protein. To focus our screen on the specific effects of E4-ORF3 and to avoid potential effects of other Ad5 regulatory proteins on host posttranslational modifications, we compared wildtype Ad5-infected cells to cells infected with ⌬E4-ORF3. We chose to compare Ubl conjugation patterns between these two viruses, since they are identical in viral protein expression, with the exception of the E4-ORF3 protein. We did not compare Ad5-infected cells to uninfected cells, since we anticipated that patterns of sumoylation, as well as ubiquitin and other Ubl modifications, un-
FIG 1 Validation of HeLa cell stable expression of His 6 -SUMO3(T90R). (A)
The amino acid sequences to the N terminus of the diglycine residues in mature ubiquitin, Nedd8, ISG15, SUMO1, SUMO2, SUMO3, and SUMO3(T90R) are shown. Peptides that would be generated following trypsin cleavage of a conjugated substrate are shown in red. (B) Expression levels of SUMO2/3 and His 6 -tagged SUMO3 in parent HeLa and His 6 -SUMO3 and His 6 -SUMO3(T90R)-HeLa cells. Total cell lysates were analyzed by Western blotting with anti-SUMO-2/3, anti-His, and anti-␥-tubulin antibodies. Molecular mass markers are indicated on the left. (C) SUMO3 and SUMO3(T90R) conjugation to Nbs1 during Ad5 infection. Cells were infected with Ad5 for 7 h, SUMO conjugates were prepared using Ni-NTA-agarose beads under denaturing conditions, and increasing amounts of eluates were analyzed by Western blotting (His pulldown). RanGAP1 was analyzed as a sumoylation control. Increasing amounts of total cell lysates were analyzed by Western blotting with anti-Nbs1 and anti-His antibodies. (D) Subnuclear localization of His 6 -SUMO3 (top three rows) and His 6 -SUMO3(T90R) (bottom three rows) proteins. His 6 -tagged SUMO3 and SUMO3(T90R)-expressing HeLa cells were uninfected or infected with wild-type or E4-ORF3-deficient Ad5 for 7 h. SUMO3 proteins were immunostained using the anti-His antibody. E4-ORF3 and E2-DBP were used as markers for infected cells. Nuclei were visualized by DAPI staining (DNA).
related to E4-ORF3 expression might change, since the process of viral infection itself induces cellular signaling, including the mitogen-activated protein (MAP) kinase and integrin signaling pathways (29) , and because other Ad5 regulatory proteins alter posttranslational modifications, including protein ubiquitination and sumoylation (30, 31) . His 6 -SUMO3(T90R)-expressing HeLa cells (2 ϫ 10 8 ) were infected with Ad5 or ⌬E4-ORF3 for 7 h, harvested, and submitted to Cell Signaling Technology for PTMScan analysis using the K-ε-GG ubiquitin remnant motif antibody. We evaluated samples by Western blotting for SUMO2/3 and His 6 -SUMO3(T90R) expression levels and global conjugation patterns. These patterns were the same with both virus infections ( Fig. 2A) .
Ad5 E1A expression levels were also the same with both viruses, whereas the E4-ORF3 protein was only detected in cells infected with wild-type Ad5. The complete results of this analysis are presented in Table S1 in the supplemental material. A total of 7,792 redundant peptide assignments were made, with 4,477 nonredundant peptide assignments identified using the ubiquitin remnant motif antibody. The levels of the majority of these peptides (i.e., Ubl conjugation sites) were not changed in a statistically significant manner between the samples from cells infected with wildtype Ad5 versus those infected with ⌬E4-ORF3. Cellular and Ad5 proteins whose K-ε-GG motif modification was changed Ն2-fold by E4-ORF3 expression and with a peptide intensity measurement of Ͼ1,000,000 or that were changed Ն2.5-fold and with a peptide intensity measurement of Ͼ200,000 are listed in Table 1 according to the fold change from greatest to least, either increased (top group) or decreased (bottom group). A total of 166 K-ε-GG modification sites were identified in 51 proteins that were altered positively or negatively by Ad5 E4-ORF3 expression using these criteria. Modification at the majority of these sites (153/166) and in the majority of proteins (41/51) was increased in Ad5-infected cell samples compared to ⌬E4-ORF3-infected cell samples. Most of these sites were identified in cellular proteins, but one was identified in the Ad5 DNA binding protein (DBP) (see Table S1 in the supplemental material). The number of conjugation sites identified in the 51 cellular proteins altered by E4-ORF3 expression ranged from only 1 site altered (28 proteins), 2 sites altered (10 proteins), 3 to 8 sites altered (9 proteins), to 10 or more sites altered (4 proteins). Among this list were Nbs1 and Mre11, which were previously identified as proteins whose SUMO2/3 conjugation is induced by Ad5 E4-ORF3 (11) .
Ubiquitin and Nedd8 conjugation patterns and localization are not altered by Ad5 E4-ORF3. The analysis of a K-ε-GG linkage would identify SUMO3(T90R) conjugation sites but also may identify conjugation of ubiquitin itself, as well the Ubl proteins Nedd8 and ISG15, which all contain an arginine residue upstream of the diglycine conjugation site (Fig. 1A) . The proteins identified in this study with K-ε-GG modifications regulated by E4-ORF3 are listed in Table S2 in the supplemental material, with known SUMO, ubiquitin, Nedd8, and ISG15 modifications listed and referenced. We analyzed whether E4-ORF3 expression altered global patterns of ubiquitin, Nedd8, and ISG15 protein conjugation by 7 h after infection. HeLa cells were infected with Ad5 or ⌬E4-ORF3, and total cell lysates were prepared using denaturing conditions. Western blot analyses were performed using antibodies directed against ubiquitin, Nedd8, and ISG15 (Fig. 2B) . The patterns of total ubiquitin or Nedd8 conjugation were indistinguishable following infection with either virus. ISG15 conjugation was not apparent in unstimulated HeLa cells but was induced following IFN-␣ treatment, consistent with the fact that ISG15 is an interferon-stimulated gene (ISG) product (32) . Since Ad5 infection is known to alter the ubiquitination of a number of cellular substrates (4-6, 33-38), total ubiquitin conjugation patterns observed using whole-cell lysates were confirmed by immunoprecipitation (Fig. 2C) . No changes were evident in cells infected with Ad5 or ⌬E4-ORF3 in comparison to uninfected cells. The lack of change in global ubiquitin and Nedd8 conjugation patterns following E4-ORF3 expression was not surprising, since the same was true with global SUMO2/3 conjugation patterns ( Fig. 2A) . We had previously correlated the induction of SUMO conjugation to Mre11 and Nbs1 induced by the E4-ORF3 protein with the relocalization of SUMO1 and SUMO2/3 into E4-ORF3-containing nuclear tracks (11) . Therefore, we examined the subcellular localization of ubiquitin and Nedd8 following infection of HeLa cells with Ad5 or ⌬E4-ORF3. Wild-type Ad5 infection did not alter the subcellular distribution of ubiquitin or Nedd8 compared to uninfected cells at 7 h postinfection ( Fig. 2D and E) . We concluded that the Ad5 E4-ORF3 protein does not alter global patterns of ubiquitin, Nedd8, or ISG15 protein conjugation, or the subcellular localization of ubiquitin or Nedd8.
The Ad5 E4-ORF3 protein induces sumoylation of multiple cellular substrates. We next examined the conjugation of SUMO3 to several K-ε-GG conjugation substrates (listed in Table 1 ). Parental HeLa cells or His 6 -SUMO3-expressing HeLa cells were left uninfected or infected with Ad5 or ⌬E4-ORF3 for 7 h, and patterns of total SUMO3 conjugation or SUMO3 conjugation to specific substrates were examined (Fig. 3A and B) . Patterns of total SUMO3 conjugation were not changed following infection with either virus in comparison to uninfected cells in whole-cell extracts (Fig.  3A, lysate) or in Ni-NTA-purified samples (Fig. 3A, His pulldown) . RanGAP1 served as an internal control. Wild-type Ad5, but not ⌬E4-ORF3, induced the conjugation of SUMO3 to Nbs1 and Mre11 with multiple sumoylated species evident (Fig. 3B, His  pulldown) , as we previously reported (11) . Comparable levels of these proteins were evident in whole-cell extracts from uninfected and Ad-infected cells (lysate). Conjugation of SUMO3 to TIF1␥ and PML was evident with uninfected cells and also was observed in cells infected with both viruses, with multiple sumoylated species observed in both cases (Fig. 3B) . SUMO3 conjugation to TIF1␥, however, was augmented following infection with wildtype Ad5, in comparison to uninfected and ⌬E4-ORF3-infected cells. No obvious differences were evident in the patterns of PML-SUMO3 conjugation following infection with wild-type Ad5 versus the E4-ORF3 mutant virus. Since multiple SUMO3-conjugated PML species were evident, it is difficult to determine if sumoylation was induced or if conjugation sites were altered during Ad infection using this assay.
A substrate whose modification is abundantly altered by E4-ORF3 expression is transcription factor II-I (TFII-I/GTF2-I), with 37 sites changed 2-fold or more. TFII-I has not been previously associated with E4-ORF3 function or Ad5 infection. As observed with TIF1␥ and PML, TFII-I was sumoylated in uninfected cells, consistent with previous reports (14, 39) (Fig. 3B) . Infection with wild-type Ad5, but not ⌬E4-ORF3, augmented TFII-I sumoylation compared to uninfected cells (Fig. 3B) . It is also possible that E4-ORF3-induced polysumoylation of TFII-I could account for the new higher-molecular-weight species observed in Ad5-infected cell extracts. Changes in TFII-I levels in Ad-infected cell extracts were not reproducibly observed. We also examined TFII-I subcellular localization in uninfected cells and wild-type Ad5-and ⌬E4-ORF3-infected cells (Fig. 3C) . A diffuse nuclear distribution was observed in uninfected cells and cells infected with the E4-ORF3 mutant virus. In contrast, TFII-I was relocalized into E4-ORF3 tracks following infection with wild-type Ad5. These results verify that wild-type Ad5 infection induces selective SUMO3 modification of cellular proteins and that TFII-I is a new cellular target of Ad5 E4-ORF3.
Finally, we compared the total K-ε-GG conjugation sites identified in this analysis to those regulated by E4-ORF3 and aligned these sites to determine if a consensus sequence exists for E4-ORF3 targeting (Fig. 4) . Of the total K-ε-GG conjugation sites identified, 4,311 were not affected by E4-ORF3 expression, whereas 166 sites were affected (153 sites increased, 13 sites decreased). Of the total proteins with K-ε-GG conjugation sites identified, 1,669 were not affected by E4-ORF3 expression, whereas 51 proteins were affected (41 increased, 10 decreased) (Fig. 4A) . Of the K-ε-GG conjugation sites affected by E4-ORF3 expression, there was no notable consensus motif identified with the total sites, or with sites whose modification was increased or decreased (Fig. 4B) . SUMO conjugation by E3 ligases frequently involves nonconsensus lysine residues (12, 13) . 
DISCUSSION
We previously described that the Ad5 E4-ORF3 protein induces sumoylation of Mre11 and Nbs1 (11) . We observed multiple E4-ORF3-induced SUMO conjugates of Nbs1 and Mre11 (also observed in this study [ Fig. 3B]) . The mobilities in SDS-PAGE of the fastest-migrating sumoylated Nbs1 and Mre11 species were consistent with the conjugation of two SUMO moieties, based on the observation that each SUMO modification reduces protein mobility in an SDS-PAGE gel by ϳ20 kDa. We anticipated that the Nbs1 species represented independent sumoylation sites rather than polysumoylation at a single lysine residue, since the number of bands was the same with SUMO1 and SUMO2/3 and because SUMO1 is not reported to form multichain linkages (12, 13) . Only SUMO2/3 linkages were found with Mre11 that could correspond to mono-or polysumoylation. The results of the present study identified multiple sites of Ubl conjugation to Mre11 and Nbs1 induced by Ad5 E4-ORF3: seven sites on Mre11 and three sites on Nbs1. Our results also revealed Ubl conjugation to the Mre11/ Nbs1 binding partner Rad50, with 13 identified conjugation sites induced by E4-ORF3 expression (see Table S1 in the supplemental material). While our studies were ongoing, Hay and colleagues reported the use of a 293 cell line that stably expresses His 6 -SU-MO2-T90K and the use of the PTMScan ubiquitin remnant motif antibody to identify cellular proteins conjugated to SUMO2 following heat shock (39) . That analysis identified 1,002 sumoylated peptides in 539 substrate proteins. Interestingly, there was little overlap between the SUMO2 conjugation sites identified in their study in comparison to K-ε-GG conjugation sites identified in the present study, with overlap found with only 11 conjugation sites in five different proteins (TFII-I, Mre11, TIF1, UTP14, and SUMO2 [see Table S3 in the supplemental material]). Two SUMO conjugation sites were identified in Mre11 following heat shock that corresponded to two of the seven sites identified in the present study (K255 and K416). No SUMO conjugation sites were identified in Nbs1 or Rad50 following heat shock, compared to 16 total sites in these two proteins induced by Ad5 E4-ORF3 expression. Sumoylation of all three MRN components, Mre11, Rad50, and Xrs2 (Nbs1), was observed in Saccharomyces cerevisiae following the induction of a DDR by replicative stress. Protein sumoylation induced by a DDR is widespread in this organism (40) . The yeast MRX complex serves as a positive regulator of sumoylation, and sumoylation significantly promotes the DDR in this system (40) . Ribet and colleagues also recently reported the use of HeLa cell lines that stably express His 6 -SUMO1-T95R and His 6 -SUMO2-T91R and use of the PTMScan ubiquitin remnant motif antibody to identify cellular proteins constitutively conjugated to SUMO1 or SUMO2 (41) . That analysis identified 295 SUMO1-conjugated peptides in 227 substrate proteins and 167 SUMO2-conjugated sites in 135 substrate proteins. Only two of these conjugation sites overlapped with those identified in the current study, one in TFII-I and one in TIF1␥ (see Table S3 ). Ubiquitination and sumoylation have emerged as important posttranslational modifications that regulate DDRs and DNA repair (42) . Proliferating cell nuclear antigen (PCNA) is sumoylated at residue K164 during S phase, which recruits the DNA helicase Srs2 via a SUMO interaction motif (SIM) to restrict DNA recombination (43) . The SUMOs (SUMO-1, SUMO-2, and SUMO-3), as well as components of the SUMO machinery, accumulate at sites of DNA damage to direct the sumoylation of proteins involved in DNA repair, such as BRCA (44, 45) . Sumoylation increases BRCA1 Ub ligase activity. The E3 SUMO ligases protein inhibitor of activated STAT 1 and 4 (PIAS1 and PIAS4) localize at sites of DNA damage and are required for efficient DNA repair and recruitment of other effectors involved in a DDR (44, 45) . Ad5 E4-ORF3 expression altered K-ε-GG conjugation of 51 cellular proteins identified in this study, mostly by inducing (41/51 substrates) rather than reducing this modification. The induction of K-ε-GG modification of the MRN components by E4-ORF3 was particularly notable, since Mre11, Nbs1, and Rad50 represented 7.3% of the total proteins whose modification was increased by E4-ORF3, whereas K-ε-GG conjugation sites identified on these proteins represented 15% of the total modifications induced by E4-ORF3. Inhibition of the DDR during Ad infection is critical for successful virus replication (1, 2) , and we propose that sumoylation of the MRN components promotes this process. The identification of specific SUMO3-conjugated lysine residues in these substrates will facilitate functional analyses in the future. A second group of cellular proteins with K-ε-GG modification induced by Ad5 E4-ORF3 contained two proteins in the TRIM (TRIpartite Motif) family, PML (TRIM19) and TIF1␥ (TRIM33). Both proteins are known binding partners of Ad5 E4-ORF3 (46, 47) , but the induction of their sumoylation by E4-ORF3 was not previously reported. E4-ORF3 induced SUMO3 conjugation at eight sites in PML and six sites in TIF1␥. Again, these two SUMO3 substrates are overrepresented in our data set, where they represent 4.8% of the proteins whose modification was regulated by E4-ORF3 but contain 9.2% of the total K-ε-GG conjugation sites. TRIM family proteins are involved in intrinsic and interferoninduced antiviral immunity (48) . PML inhibits immediate-early gene expression and viral replication of human herpesviruses herpes simplex virus 1 and human cytomegalovirus (49) . Both of these viruses have evolved mechanisms to prevent PML restriction of viral replication. The Ad E4-ORF3 protein relocalizes PML and associated components Daxx and Sp100 into nuclear tracks to sequester their activities (9, 10) . In the absence of E4-ORF3, interferons block viral early gene expression and viral DNA replication (9, 10) . The induction of PML sumoylation by E4-ORF3 may be involved in this process, since PML sumoylation and the interaction of PML with SUMO through SUMO interaction motifs (SIMs) regulates PML-NB formation (50) . It is an attractive hypothesis that Ad5 E4-ORF3 regulates cellular protein sumoylation to disrupt PML-NBs, as well as to recruit PML, PML-associated proteins, and other cellular effectors into E4-ORF3 nuclear tracks. Of the cellular proteins previously reported to be associated with E4-ORF3 nuclear tracks, most were identified in this study, including Mre11, Rad50, Nbs1, PML, and TIF1␥. However, several other cellular proteins known to associate with E4-ORF3 were not identified in these studies (e.g., Daxx, Sp100, TIF1␣). If the induction of SUMO modification is involved in E4-ORF3 recruitment of cellular proteins into nuclear tracks, it is possible that Daxx, Sp100, and TIF1␣ are relocalized during Ad infection via alternative protein-protein interactions, such as the interaction of PML with Daxx and Sp100 (51) or the interaction of TIF1␣ with TIF1␥ (52).
TFII-I was abundantly modified following Ad5 E4-ORF3 expression, with a total of 37 K-ε-GG conjugation sites identified (see Table S1 in the supplemental material). We verified that E4-ORF3 induces TFII-I sumoylation, with one or more additional SUMO3 conjugates detected (Fig. 3B) . TFII-I was also found to relocalize to E4-ORF3 nuclear tracks following wild-type Ad5 infection (Fig. 3C) . In addition to TFII-I sumoylation, Ub conjugation to TFII-I has been reported for 11 of the 37 K-ε-GG sites identified in the present analysis (53, 54) (see Table S3 in the supplemental material). Therefore, some of the sites identified here may represent ubiquitin conjugation rather than SUMO conjugation. Twelve SUMO2 conjugation sites on TFII-I also were observed following heat shock (39) , with six of these sites overlapping with those identified in the current analysis (see Table S3 ). TFII-I plays a role in numerous signaling pathways that regulate cellular gene expression, including transforming growth factor ␤, calcium, and stress signaling (55) . TFII-I interacts with PIASx (Miz1/Siz2), an E3 SUMO ligase, and histone deacetylase 3 (HDAC3), as part of a transcriptional activating complex (56, 57) . How TFII-I activity may be regulated in response to signaling events and by sumoylation is not known.
The remainder of the proteins with K-ε-GG modifications induced by E4-ORF3 fell into a number of different functional categories and may, or may not, represent bona fide E4-ORF3 sumoylation targets. We favor the view that many of the modification sites identified in this analysis, in fact, represent E4-ORF3-induced sumoylation, since we previously found a strict correlation between relocalization of SUMO proteins into E4-ORF3-containing nuclear tracks and the ability of E4-ORF3 to direct sumoylation of Mre11 and Nbs1 (11) . Since the subcellular localizations of ubiquitin and Nedd8 were not altered by E4-ORF3 expression ( Fig. 2D and E ), it appears that these proteins may not be positioned appropriately in infected cell nuclei to be conjugated to substrates recruited by the E4-ORF3 protein. Table S3 displays all of the E4-ORF-induced K-ε-GG conjugation sites identified in the present study with overlapping sites within these proteins known to be sites of ubiquitin conjugation identified in large-scale proteomic analyses (22, 53, 54) . The latter two referenced studies utilized the K-ε-GG antibody from Cell Signaling Technology to identify proteins conjugated to ubiquitin and conjugation sites. Fifty-four of the 166 K-ε-GG conjugation sites identified in the present study were also identified as ubiquitin conjugation sites. While there is overlap with one-third of the K-ε-GG conjugation sites identified in the present study, twothirds of the K-ε-GG conjugation sites induced by E4-ORF3 are unique and likely represent protein sumoylation. Finally, we note that the TIF1 family members TIF1␤ (TRIM28) and TIF1␥ (TRIM33) have intrinsic SUMO E3 ligase activities, as do several other TRIM family members (58) (59) (60) (61) . One or more of these proteins may play a role in E4-ORF3-induced sumoylation in vivo. We also cannot rule out the possibility that the E4-ORF3 protein itself possesses SUMO ligase activity. Future analyses will be required to determine how the E4-ORF3 protein regulates the K-ε-GG modification of cellular substrates and the functional consequences of these events.
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